Profound Medical Company Executives

PRN Stock  CAD 10.21  0.29  2.92%   
Profound Medical employs about 142 people. The company is managed by 10 executives with a total tenure of roughly 332 years, averaging almost 33.0 years of service per executive, having 14.2 employees per reported executive. Analysis of Profound Medical's management performance can provide insight into the firm performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Profound Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.6244) % which means that it has lost $0.6244 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.2449) %, meaning that it generated substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Profound Medical owns a total of 36.29 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Profound Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Profound Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Profound Medical Workforce Comparison

Profound Medical Corp is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 3,717. Profound Medical holds roughly 142 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (2.75) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.69) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.69.

Profound Medical Corp Benchmark Summation

Operator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Profound Medical Corp Price Series Subtraction is a subtraction of Profound Medical price series from its benchmark/peer..

Profound Medical Notable Stakeholders

A Profound Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Profound Medical often face trade-offs trying to please all of them. Profound Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Profound Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Arun MBAChairman CEOProfile
Hartmut WarnkenSenior AlliancesProfile
Jacques CornetSenior SonalleveProfile
Stephen KilmerInvestor RelationsProfile
Mathieu BurtnykSenior TULSAPROProfile
Thomas MBAChief OfficerProfile
Abbey GoodmanChief GlobalProfile
Levant TinazSoftware DeveloperProfile
Michael MydraVP AccessProfile
Rashed DewanChief OfficerProfile
String symbol = request.getParameter("s");

About Profound Medical Management Performance

The success or failure of an entity such as Profound Medical Corp often depends on how effective the management is. Profound Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Profound management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Profound management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. PROFOUND MEDICAL operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 64 people.

Profound Medical Workforce Analysis

Traditionally, organizations such as Profound Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Profound Medical within its industry.

Profound Medical Manpower Efficiency

Return on Profound Medical Manpower

Revenue Per Employee75.2K
Revenue Per Executive1.1M
Net Loss Per Employee195.9K
Net Loss Per Executive2.8M
Working Capital Per Employee440.1K
Working Capital Per Executive6.2M
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Profound Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.